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Popliteal artery volume flow measurement: A new
and reliable predictor of early patency after
infrainguinal balloon angioplasty and
subintimal dissection
Enrico Ascher, MD, Anil P. Hingorani, MD, and Natalie A. Marks, MD, RVT, Brooklyn, NY
Objective: We have investigated whether popliteal artery volume flow (PAVF) measured immediately after balloon
angioplasties of the superficial femoral artery–popliteal segments (SFA/POP) was predictive of early (30 days) and
mid-term (6 months) arterial thrombosis.
Methods: During the last 24 months, 203 patients (56% men) with a mean age of 73  9 years had 268 duplex-guided
balloon angioplasties of the SFA/POP. Critical ischemia was the indication in 36%. Group I included 176 (66%) with
stenoses, and group II had 92 (34%) with occlusions. All patients had completion duplex examinations that included three
measurements of PAVF of below-the-knee popliteal artery.
Results: Early (30 days) thrombosis of the treated femoropopliteal arterial segment developed in 10 patients (3.7%), three
in group I (1.7%) and seven in group II (7.6%; P < .04). All 10 cases of early thrombosis were in patients with
TransAtlantic Inter-Society Consensus (TASC) class C (6/185, 3.2%) and D (4/26, 15%) lesions. Moreover, the 19%
incidence (n  4) of early thrombosis in patients with PAVF <100 mL/min (mean, 73  24 mL/min; range, 20 to
99 mL/min) was higher compared with the 2.4% rate for patients with higher flows (mean, 176  60 mL/min; range,
100 to 450 mL/min; P < .01). At 6 months of follow-up, femoropopliteal occlusions had developed in nine more
patients, and it became apparent that low PAVF measurements were still predictive of thrombosis (29%) when compared
with higher PAVF cases (6%; P < .002). Log-rank comparison of survival curves for cumulative primary stenosis-free
patency in group I and group II demonstrated a statistically significant difference (P < .02). PAVF <100 mL/min and
TASC classification were significant predictors of early (30 days) and mid-term (6 months) arterial thrombosis after
femoropopliteal angioplasties. PAVFwas themost powerful predictor of arterial thrombosis. The respective 6-month and
12-month limb salvage rates were 98% and 94% for patients with claudication and 88% and 85% for those with
limb-threatening ischemia (P < .0001).
Conclusions: Our results demonstrate that low PAVF is the most powerful predictor of early (30 days) and mid-term (6
months) arterial thrombosis after femoropopliteal interventions. In the presence of a low postprocedure PAVF (<100
mL/min), one may consider not reversing the heparin or using intermittent calf compression, or both, to augment the
arterial flow. (J Vasc Surg 2007;45:17-24.)The advent of high-resolution duplex imaging has al-
lowed our group to image the vascular tree from the aorta
to pedal vessels with sufficient accuracy to plan out the
revascularization without the need for additional imaging
modalities.1-5 More recently, we extended this experience
to endovascular procedures. Since then, the role of duplex-
guided angioplasties in patients with lower extremity isch-
emia has been an area of great interest at our institution.6-8
One of the advantages of using duplex scanning over
standard arteriography is the possibility of performing he-
modynamic evaluation of the treated arterial segment. An-
other is the feasibility of measuring volume flows distal to
the angioplasty site. It is logical to assume that patients with
low volume flow in the below knee popliteal artery after
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doi:10.1016/j.jvs.2006.09.042balloon angioplasties of the ipsilateral superficial femoral
artery (SFA) are at increased risk of thrombosis compared
with patients with higher volume flows. In an attempt to
validate this hypothesis, we prospectively evaluated the role
of popliteal artery volume flows (PAVF) after angioplasty as
a potential predictor of early arterial thrombosis. We also
compared several other potential indicators of early success
or failure after angioplasty, including the presence of critical
limb ischemia, diabetes mellitus, runoff score, and Trans-
Atlantic Inter-Society Consensus (TASC) classification.
METHODS
Patients. During the last 24months at our institution,
203 patients had 268 duplex-guided balloon angioplasties
of the superficial femoral or popliteal arterial segment, or
both, on 226 limbs. The series included 114 men (56%)
and 89 women (44%), and their mean age was 73 9 years
(range, 42 to 97 years). Concomitant risk factors were
hypertension in 160 patients (79%), diabetes mellitus in 99
(49%), smoking in 87 (43%), and coronary artery disease in
79 (39%); in addition, 71 (35%) had elevated serum creat-
inine levels (1.5 mg/dL). Indications for the procedure
17
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ischemic ulcers in 53 (20%), and gangrene in the remaining
26 (10%).
Preoperative evaluation. Preoperative duplex arte-
riography was performed in all patients by an experienced
registered vascular technologists according to a protocol
previously published by our group.1,2 Imaging findings
were confirmed by physiologic examinations, including
pulse volume recordings and ankle-brachial indices (ABIs).
If ABIs were unavailable owing to nonaudible pulses or
noncompressible calcified arteries, we recorded ankle trac-
ings amplitude. Duplex arteriography showed a severe ste-
nosis or occlusions, or both, in the superficial femoral artery
(SFA) or popliteal artery, or both, in all cases. Group I
included 176 cases (66%) with severe arterial stenoses de-
fined as a diameter reduction of 70% measured on color
or power image and confirmed by a peak systolic velocity
step-up of 3. Of these, 127 were primary cases and 49
were restenoses. Group II had 92 cases (34%) with arterial
occlusions; 86 of these were primary cases and six were
reocclusions. Femoropopliteal lesions were classified using
TASC criteria. There were 17 class A lesions (6%), 40 class B
(15%), 185 class C (69%), and the remaining 26 (10%) were
class D.
An average of 2.2 0.85 patent nondiseased infrapop-
liteal arteries was found for all patients. There were 126
cases (47%) with all three infrapopliteal arteries patent and
without significant stenoses (50%), 81 (30%) with two
arteries, 54 (20%) with one artery, and in the remaining
seven (3%), all three arteries were severely diseased or
occluded.
Technique. All procedures were duplex-guided bal-
loon angioplasties performed in the operating room using a
technique described in previous publications.6-8 A Philips
HDI 5000 duplex scanner with SonoCT feature (Philips
Medical Systems, Bothell, Wash) was routinely used. The
approach was antegrade through the common femoral
artery (CFA) in 242 cases (90%) and through the contralat-
eral CFA in the remaining 26 (10%). Contralateral CFA
access required ipsilateral common iliac artery cannulation
under fluoroscopy alone in four cases and with 10mL to 20
mL of contrast in the remaining 22. Visipaque (Amersham
Health, Princeton, NJ) was used in 18 cases and Magnevist
(Berlex Laboratories, Wayne, NJ) in the remaining four.
Immediately before prepping and draping the patient,
we confirmed preoperative duplex findings and marked the
stenotic and occlusive arterial lesions on the skin. In addi-
tion, we measured PAVF using color duplex imaging and
spectral analysis behind the knee three times and recorded
an average value. Volume flow was obtained with the
Doppler angle adjusted at 60° and the sample volume equal
or larger than the arterial lumen. Mean values  SD and
ranges were reported.
A sample of PAVF was recorded three times immedi-
ately after completion of the procedure and immediately
after the intra-arterial administration of 30 mg of papaver-
ine sulphate. Biplanar scanning of the femoropopliteal ar-
terial segment was performed at the completion of theprocedure in all cases. Hemodynamically significant resid-
ual defects (plaque dissections and recoils) causing diame-
ter reduction of 30% and a peak systolic velocity ratio of
2 were stented with a variety of self-expandable stents
under duplex guidance. Duplex assessment of the tibio-
peroneal trunk and all three infrapopliteal arteries was
performed at the end of the procedure in all cases.
Postprocedure evaluation and follow-up. Arterial
duplex pulse volume recordings, including ABIs, were ob-
tained in all patients before hospital discharge and during
regular postprocedural follow-up visits in the outpatient
office1 month and every 3 months thereafter. Recurrent
stenosis was defined as an arterial diameter reduction70%
measured by color Doppler imaging and confirmed by a
local peak systolic velocity step-up of3. Arterial occlusion
was confirmed by absence of color or power signal in the
arterial lumen.
Statistical analysis. Fisher’s exact test was used to
compare the incidence of low PAVF in group I and group
II, incidence of 30 day and 6-month arterial thrombosis for
group I and group II, and lower and higher PAVF. The
paired t test (parametric distribution) was used to compare
preprocedure, postprocedure, papaverine-induced PAVF,
and ABIs and forefoot pulse volume recording tracings
before and after angioplasty. The same analysis was used to
compare PAVF for patients with poor (0 to 1 arteries) vs
good (2 to 3 arteries) runoff. The statistical software Instat
3.06 (GraphPad Software, San Diego, Calif) for Windows
(Microsoft Corp, Redmond, Wash) was used for these
calculations.
Arterial patency life tables (Kaplan-Meier survival test
and log-rank comparison of the survival curves) for group I
and group II, patients with claudication vs patients with
critical limb ischemia, and different TASC classified lesions
were calculated using GraphPad Prism 4.00 (GraphPad
Software). Similar analysis was performed for calculation
and comparison of limb salvage rates in patients with clau-
dication and critical limb ischemia.
Multiple linear regression analysis of five potential in-
dependent factors contributing to early (30 days) and mid-
term (6 months) arterial thrombosis, (1) PAVF 100
mL/min, (2) TASC classification, (3) run-off score, (4)
critical limb ischemia as an indication for intervention, and
(5) presence of diabetes mellitus, was performed using the
Unscrambler 9.6 software (CAMO Software Inc, Wood-
bridge, NJ).
RESULTS
Technical defects and stenting. An average of 1.6 
0.9 stents (range, 1 to 5 per case) were placed for treatment
of residual lumen defects in 172 (64%) of the 268 cases.
The reasons for stenting were plaque recoil in 90 (52%),
dissection in 42 (25%), or both in 40 (23%).
Patency rates and limb salvage. The overall cumula-
tive primary stenosis-free patency calculated by life-table
analysis for 268 femoropopliteal duplex-guided balloon
angioplasties and comparison between stenotic (group I)
and occlusive (group II) femoropopliteal lesions is pre-
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stenosis-free patency of patients with claudication vs limb-
threatening ischemia is summarized in Table II. Two above
knee amputations (0.9%) were performed in the entire
series, and both patients (2.5%) were in the group with
limb-threatening ischemia. This difference was not statisti-
cally significant (P .12). The 12-month limb salvage rate
was 94% for patients with claudication, and 85% for those
with limb-threatening ischemia (P  .0001).
Comparison of preoperative and intraoperative
popliteal artery volume flow. The mean preoperative
PAVF for all patients was 60  28 mL/min (range, 6 to
149 mL/min). In these patients, the postintervention
mean baseline PAVF was 169 65 mL/min (range, 20 to
450 mL/min), an increase that was statistically significant
(P  .001). All patients demonstrated a PAVF increase
after the intra-arterial infusion of 30 mg of papaverine. The
mean PAFV increase was 388 213mL/min (range, 90 to
1350 mL/min), or 134%  92% (range, 13% to 567%),
which was statistically significant (P  .001). However,
the increase of PAVF noted after papaverine administra-
tion was not a significant predictor of early arterial
thrombosis (P  .30).
Correlation of arterial patency with postangio-
plasty popliteal artery volume flow. In 21 (7.8%) of the
268 cases, the baseline mean PAVF was 100 mL/min
(mean, 73  24 mL/min; range, 20 to 99 mL/min). Of
these, 16 were in the group of 176 transluminal angioplasty
Table I. Cumulative primary stenosis-free patency
calculated by life-table analysis for 268 femoropopliteal
duplex-guided balloon angioplasties overall and
comparison between stenotic (group I) and occlusive
(group II) femoropopliteal lesions
Time point
Group
Overall (%)
(n  268)
Group I (%)
(n  176)
Group II (%)
(n  92)
3 months 97 99 89
6 months 83 87 75
12 months 53 55 51
Table II. Comparison of cumulative primary stenosis-free
patency calculated by life-table analysis between
femoropopliteal duplex-guided balloon angioplasties in 172
cases with claudication vs 96 with critical limb ischemia*
Time point
Indication
Claudication (%)
(n 172)
Critical limb ischemia (%)
(n 96)
3 months 97 88
6 months 88 73
12 months 64 42
*Survival curves were significantly different with P  .0001.cases (9%), and the remaining five (5.4%) were from the 92subintimal angioplasty cases (P  .30). Early (30 days)
thrombosis developed in the treated femoropopliteal arte-
rial segment in 10 patients (3.7%), of which three were
from group I (1.7%) and seven (7.6%) were in group II
(P  .04).
The incidence of early thrombosis was 19% in patients
with PAVF100 mL/min (n 4) and 2.4% (n 6) when
higher flows were recorded (P  .01). At the 6-month
follow-up, femoropopliteal occlusions developed in 9 more
patients, and it became apparent that low PAVF measure-
ments were still predictive of thrombosis (29%) compared
with higher PAVF cases (6%; P .002). Log-rank compar-
ison of survival curves for patency in group I and group II
demonstrated a statistically significant difference (P .02).
Correlation of postangioplasty popliteal artery
volume flow and primary patency with TASC lesion
classification. All 10 cases of early thrombosis were in pa-
tients with TASC class C (6/185, 3.2%) or class D (4/26,
15%) lesions. Preoperative and postoperative PAVF for pa-
tients classified using TASC criteria are listed in Table III. The
correlation of stenosis-free patency with TASC classification
for the treated femoropopliteal segments is summarized in
Table IV.
Correlation of postangioplasty popliteal artery vol-
ume flow and infrapopliteal runoff. Patients with poor
runoff (0 to 1 patent arteries) had a mean PAVF of 153 
75 mL/min, and patients with better runoff (2 to 3 patent
arteries) had amean PAVF of 173 62mL/min (P .04).
Multivariate linear regression analysis of factors
predictive of postprocedure arterial thrombosis. PAVF
100 mL/min was found to be the most powerful predic-
tor of early (30 days) and mid-term (6 months) arterial
thrombosis after femoropopliteal balloon angioplasties.
Corresponding data are listed in Table V and Figs 1 and 2.
Adjunctive infrapopliteal angioplasties. Adjunctive
infrapopliteal artery angioplasties were required in 49 cases
(18%) in this series in an attempt to improve run-off. Of
these, 28 (29%) were in the group of 96 patients with
critical limb ischemia, and 21 (12%) were in the group of
172 patients with claudication. This difference was statisti-
cally significant (P  .009). The mean PAVF of 153  64
mL/min in 49 cases with infrapopliteal angioplasties was
not significantly different from the mean PAVF of 172 
66 mL/min in the remaining 219 cases without infrap-
opliteal angioplasties (P  .06). The comparison of
cumulative primary stenosis-free patency rates for pa-
tients with and without infrapopliteal angioplasties is
presented in Table VI.
Comparison of balloon angioplasties for primary
stenoses and restenoses. The mean PAVF was 169  61
mL/min after 127 primary angioplasties and 165  57
mL/min in 49 angioplasties for restenoses (P  .70). The
mean PAVF was 385  196 mL/min after administration
of papaverine in primary angioplasties and 381  217
mL/min in redo angioplasties (P  .90). The comparison
of cumulative primary stenosis-free patency for patients
with angioplasties for primary stenoses and redo angioplas-
ties is represented in Table VII.
at an
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ankle-brachial indices or pulse-volume recordings.
Of the 268 successful angioplasties, reliable ABIs were
obtained before and after the procedure in 223 cases (83%).
Ankle pulse-volume recordings amplitude tracings were
available for comparison in 45 remaining cases (17%). In
the latter cases, ABIs were considered unreliable owing to
severely calcified noncompressible arteries in 25 or nonau-
dible pulses in 20.
Overall mean ABIs for the 223 patients were 0.68 
0.14 (range, 28 to 0.98) preprocedure and 0.93  0.12
(range, 0.55 to 1.23) postprocedure (P  .0001). The
mean ankle tracings amplitude was 3  2 mm (range, 0 to
10 mm) before the procedure and 9  4 mm (range, 2 to
Table III. Comparison of preoperative, baseline intraoper
268 femoropopliteal duplex-guided balloon angioplasties c
PAVF (mL/min) A (n  17)
Preoperative 71  29
Baseline intraoperative 178  77
Papaverine-induced intraoperative 402  330
TASC, TransAtlantic Inter-Society Consensus; PAVF, popliteal artery volum
*PAVF was not statistically significantly different for any TASC class lesions
Table IV. Cumulative primary stenosis-free patency
calculated by life-table analysis for 268 femoropopliteal
duplex-guided balloon angioplasties classified using
TransAtlantic Inter-Society Consensus
Time point
TASC class (n)
A
(n  17)
B
(n  40)
C
(n  185)
D
(n  26)
3 months (%) 100 94 96 80
6 months (%) 90 81 72 60
12 months (%) 90 62 50 42
TASC, TransAtlantic Inter-Society Consensus.
Table V. Comparison of different factors predictive of
early and mid-term* arterial thrombosis after
femoropopliteal angioplasty calculated by multivariate
linear regression analysis
Predictive factor
P
30 days 6 months
PAVF 100 mL/min .00001 .00001
TASC class .0016 .0015
Runoff score .12 .01
Critical limb ischemia .39 .23
Diabetes mellitus .15 .84
PAVF, Popliteal artery volume flow; TASC, TransAtlantic Inter-Society
Consensus.
*Early defined as 30 days, mid-term as 6 months.21 mm) after for the 45 cases (P .0001). In 203 patients(91%), a significant increase of ABI of 0.15 was demon-
strated after angioplasty.
DISCUSSION
The results of the present study indicate that PAVF
measurements are reliable predictors of early thrombosis
after infrainguinal balloon angioplasty and subintimal dis-
section. Indeed, low-flow PAVF (100mL/min) is a more
powerful predictor than the number of runoff vessels,
TASC classification, presence of diabetes mellitus, or the
indication for the procedure. This was observed at 1 month
and confirmed at 6 months after the intervention. It is
important to emphasize that the data analyzed here specif-
ically evaluate arterial thrombosis and not restenosis.
We have previously shown that increased outflow resis-
tance values measured intraoperatively were reliable predic-
tors of infrainguinal bypass graft success or failure as well as
limb salvage. In our previous experience, these measure-
ments were found to be more predictive than the number
of patent outflow vessels.9-17 Thus, it is not surprising that
low PAVFs correlated with an increased likelihood of arte-
rial thrombosis after interventions. Other investigators
have correlated early failures of angioplasty with distal
runoff and degree of ischemia.18-20 In our data, the num-
ber of runoff vessels was only predictive at 6 months after
the procedure. Perhaps this criterion may become signifi-
cant with an increased experience.
Our study is unique in that we confirmed the adequacy
of the procedure in all cases by completion duplex scanning
examinations. These included visualization of the treated
arterial segment and the outflow tract with B-mode, color
Doppler, and power-angio, as well as waveform spectral
analysis. The latter included measurements of peak systolic
velocities and velocity ratios whenever indicated. Accord-
ingly, significant residual stenosis and dissections, as well as
distal embolization as potential causes of early thrombosis,
were effectively ruled out in all cases.
During this experience, we noted discrepancies between
fluoroscopy and duplex guidance for the endovascular proce-
dures.21 Although angiography provides excellent anatomic
details, it is recognized that scant hemodynamic information is
obtained. Well-documented drawbacks of contrast-based
procedures include misinterpretations of pseudo-occlusions,
lack of visualization in the presence of metal prostheses,
, and papaverine-induced popliteal artery volume flow for
fied using TransAtlantic Inter-Society Consensus criteria*
TASC class
B (n  40) C (n  185) D (n  26)
61  34 62  26 49  31
156  61 169  59 182  102
387  193 385  198 399  260
w;
y time point (all P  .05).ative
lassi
e floradiation, nephrotoxicity, and allergy to the contrast me-
pred
predi
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with duplex imaging, a high velocity or low volume flow
can prompt further examination for a missed defect that
may not have been detected by standard arteriography.
This is particularly important because biplanar or rotational
arteriography is not widely used at the present time to
confirm the adequacy of the technique.
Some authors have suggested that routine completion
duplex examinations be performed after fluoroscopically
guided balloon angioplasty.22 Because much of the inter-
vention in the fluoroscopic examination is based upon
subjective criteria, we suggest that objective indicators be
Fig 1. Multivariate linear regression analysis of factors
Fig 2. Multivariate linear regression analysis of factors
Table VI. Comparison of cumulative primary
stenosis-free patency calculated by life-table analysis
between 49 cases with adjunct infrapopliteal angioplasties
and 219 without infrapopliteal angioplasties*
Time point
Treated segment (n)
Femoropopliteal
(n  219)
Femoropopliteal and
infrapopliteal (n  49)
3 months (%) 96 87
6 months (%) 85 68
12 months (%) 56 34
*Survival curves were statistically significantly different with P  .02.acquired by duplex scanning. For example, a comparison ofpreoperative and postoperative volume flows offers an ob-
jective way to quantitate the effectiveness of the revascular-
ization in the periprocedural period. When an area of
borderline stenosis is detected in the SFA, one may choose
to rely on volume flows as a guide for reintervention; of
course, this needs to be proven with prospective studies.
Although prior reports have already determined the feasi-
bility of performing ultrasound-guided interventions,23-28
our experience suggests that hemodynamic data may pro-
vide an additional advantage compared with contrast-based
procedures.
We have confirmed the importance of the TASC clas-
sification as a reliable predictor of arterial patency after
ictive of postprocedure arterial thrombosis at 30 days.
ctive of postprocedure arterial thrombosis at 6 months.
Table VII. Comparison of cumulative primary
stenosis-free patency calculated by life-table analysis
between 127 cases with primary angioplasties and 49 with
angioplasties for restenosis*
Time point
Angioplasties (n)
Primary (n  127) Restenosis (n  49)
3 months (%) 97 93
6 months (%) 79 76
12 months (%) 65 47
*Survival curves were not significantly different, with P  .08.balloon angioplasty29; however, this classification was not
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other than low flow could have influenced these results,
including hypercoagulable states, embolization from a
more proximal source, or early formation of intimal hyper-
plasia, or a combination of these. Although these factors
were not investigated in the present series, they seem less
likely to overcome the predictive power of low PAVF.
The overall major amputation rate of 0.9% in the
present series is similar to the rates published in other
studies. As expected, this rate was higher for the patients
who presented with limb-threatening ischemia (2.5%)
compared to the patients with claudication (0%).29-31
The question of how to proceed when a low postpro-
cedure volume flow in the popliteal artery is encountered in
the absence of significant arterial defects or stenoses is
challenging. Several options are possible: (1) consider not
reversing the heparin at the end of the procedure, (2)
continue anticoagulation for the long-term, (3) use inter-
mittent calf compression to augment the arterial flow,32
and (4) perform adjunctive balloon angioplasties of the
runoff vessels to augment flow in the popliteal artery. These
suggestions have not yet been proven, and a larger experi-
ence is necessary before this protocol should be imple-
mented.
CONCLUSION
We describe a new predictive factor for early (30 days)
and mid-term (6 months) arterial thrombosis after balloon
angioplasty of the femoropopliteal segment. As the number
of endovascular procedures continues to rise, it is necessary
to investigate new variables that can reliably predict the
patency of these reconstructions.
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Dr John Blebea (Philadelphia, Pa). There appears to be a big
discrepancy between the outcome with subintimal angioplasty
versus standard transluminal angioplasty in terms of patency rates.
There is also a major decreased patency among those vessels with
low flow rate. Were the overall flow rates within the popliteal artery
less for the patients undergoing subintimal angioplasty as a group,
not just the proportion that thrombosed or had low flows later?
Dr Anil P. Hingorani. No, they weren’t. They were actually
pretty similar when we looked at the popliteal artery volume flows
at the end of the procedure. We were not able to differentiate
between these two groups.
Dr Jacob Schneiderman (Tel-Hashomer, Israel). How do
you verify that there were no distal emboli related to the proce-
dure? Are you doing any completion evaluation of the distal tree?
Dr Hingorani. As we mentioned before, with the duplex
imaging, before the procedure we look at the tibial vessels, and
after the procedure we also look at the tibial vessels. With duplex
imaging, you can actually see all the way down to the pedal vessels.
Dr Schneiderman. So you feel confident with this ultrasound
evaluation to conclude that no emboli went to the distal tree?
Dr Hingorani. We’ve already had over a thousand patients
that we’ve evaluated preoperatively for open procedures, not only
including the femoropopliteal segment but all the way down to the
tibials and the pedal vessels, and done bypasses based upon those.
However, the limitations are actually, I think, the key. You
don’t want to be doing these patients who have very calcified
vessels where you can’t see what’s going on very well. You don’t
want to be doing this in patients who have a tremendous amount of
tissue edema because you’re not going to be able to evaluate the
vessels well. You don’t want to be doing this in patients whose SFA
is 6 cm deep, you’re not going to be able to visualize and get
enough information to do these types of procedures.
Dr Hasan Dosluoglu (Buffalo, NY). I have two quick ques-
tions. You have studied a good number of stented patients, so
could you identify those who had developed more restenosis,
depending on the flow patterns. If you end up with a patient who
has suboptimal flow, and you cannot identify why that is, what do
you do with these patients?
Dr Hingorani. That second question is actually, I think, one
of the more important points. Those types of patients we persis-
tently try to look for an inflow lesion or an outflow lesion. Maybe
we missed something on the inflow and we’ll go back up and look
at the iliac arteries to make sure we didn’t miss anything. Unfor-
tunately, we haven’t very often found an inflow or an outflow
problem. And when you don’t, I usually don’t reverse the heparin
and don’t administer the protamine in these types of patients.
In general, we thought we were actually doing okay, because
in the recovery room they seemed to be doing all right. But,seemed to do much, much worse. They had much higher rates of
early thrombosis despite our maneuvers of not reversing the hep-
arin.
We were not actually able to differentiate which patients, even
with or without stenting, would have long-term patency based on
this data set.
Dr Rumi Faizer (Columbia, Mo). A few questions. First, you
must have a good reason why you’re using flow volume and not
peak velocities and waveforms. And I was wondering how you
came to that determination?
Second question. Many of us have been impressed with how
you can see a pressure gradient down the SFA and not a clear
stenosis on imaging with angio. And I thought that’s a wonderful
place for this to show itself. I was wondering if you had any
correlation between intravascular pressure gradients versus wave-
forms that you’re seeing?
And then, lastly, I was a little bit confused with how you had
such a high proportion of TASC C and D lesions, and yet the ABI
is averaging 0.68. Why such a discrepancy? I would have expected
lower ABIs in this population.
Dr Hingorani. Initially, when you want to try to start doing
these types of protocols, you don’t want to be doing the TASC Cs
and Ds. You want to start off with the thin patient, whose vessels
you can easily see, with a short focal stenosis. When you want to
start off doing these, we actually suggest that you start doing it
preoperatively and not in the operating room, and compare it to
angiography for at least the first 25, until you’re certain that your
results that you’re getting from the technologist are greater than
95% accuracy.
We have not compared pressure gradients to these patients.
But I think you’re actually bringing up one of the clear advantages
that other people have already shown in data sets, that duplex
imaging, if you take your patient that you did an SFA angioplasty
and you immediately do a duplex, you’ll find a fair number of
lesions that youmissed on angiography, even with biplanar angiog-
raphy, unfortunately. So I think that actually may contribute to
one of the reasons why we are stenting a lot more patients as
compared to our angiogram patients, because I think we are seeing
a lot more lesions that may have been missed. We are seeing a lot
more recoil. We are seeing a lot more dissection.We are seeing a lot
more residual stenoses that I think we are missing on angiography.
But we don’t have data comparing it to pressure gradients.
We do use peak systolic velocities routinely. We do use mode
B imaging before, after, and during the procedures. This data set
right now is just mostly looking at the next step, looking at
popliteal artery volume flows.
The average ABIs, I wouldn’t be able to say. That’s what the
numbers were, 0.68. 68% of our patients were claudicants, so I
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Dr Charles Brantigan (Denver, Colo). Let me change the
focus of the discussion for a moment from the technical to the
physiologic. The last statement in your conclusions in the abstract
says that “Perhaps pharmacological manipulation in this high-risk
group of patients may enhance patency rates.” I am assuming you
are talking about vasodilator therapy of some type. What therapy
are you proposing, and for how long are you proposing to use it to
enhance the patency rates?
Dr Hingorani. Unfortunately, as you know, the vasodilators
have really not really been that helpful. And right now, as I said, all
we are doing right now is not reversing the heparin. All of thesethe procedures. And actually, we are leaving them on Plavix for at
least 3 to 6 months after these procedures, irrespective of the
popliteal artery volume flows. If we encounter a low popliteal
volume flow, we’re routinely not reversing heparin, but we are not
using any dilators or such.
Dr Brantigan. So you are not actually proposing any different
pharmacologic management for the two groups of patients?
Dr Hingorani. Not yet.
Dr Brantigan. Except, perhaps, not reversing the heparin,
which many people wouldn’t do anyway.
Dr Hingorani. Not yet. I don’t think we really have that
many alternatives as of yet. That would be a point of discussion and
patients are on Plavix preoperatively and on indefinite aspirin after a possible route of further investigation.
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